1. September Is Pulmonary Fibrosis Awareness Month: Here's What One Company Is Doing To Develop A Treatment For This Deadly Disease

    By Faith Ashmore September is Pulmonary Fibrosis Awareness Month – a time dedicated to raising public consciousness and understanding about this devastating lung disease. Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive and ultimately fatal condition that causes scarr
  2. IPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis – Could GRI-0621 Be The Solution?

    By Faith Ashmore Idiopathic Pulmonary Fibrosis (IPF) is a serious chronic lung disease characterized by the thickening and stiffening of the lung tissue surrounding the air sacs. The exact cause of IPF is unknown, but it is believed to involve a combination of genetic and environm
  3. GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus

    By Faith Ashmore Inflammatory diseases are chronic conditions that involve the abnormal activation of the body's immune system, leading to chronic inflammation in various organs and tissues. Two of these diseases that are more widely known are Idiopathic Pulmonary Fibrosis (IPF) a
  4. Stocks That Hit 52-Week Lows On Monday

    By Benzinga Insights On Monday, 27 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was Apellis Pharmaceuticals (NASDAQ: APLS ) . Esports Entertainment (NASDAQ: GMBL ) was the smallest company by market c